Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
| Revenue (TTM) | $1.03B |
| Gross Profit (TTM) | $564.39M |
| EBITDA | $-43.20M |
| Operating Margin | -7.05% |
| Return on Equity | -65.70% |
| Return on Assets | -3.68% |
| Revenue/Share (TTM) | $15.16 |
| Book Value | $2.27 |
| Price-to-Book | 7.74 |
| Price-to-Sales (TTM) | 1.00 |
| EV/Revenue | 1.158 |
| EV/EBITDA | 345.75 |
| Quarterly Earnings Growth (YoY) | -37.00% |
| Quarterly Revenue Growth (YoY) | 5.50% |
| Shares Outstanding | $68.53M |
| Float | $62.99M |
| % Insiders | 0.86% |
| % Institutions | 117.91% |
Volatility is currently expanding